Stay updated on Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial

Sign up to get notified when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a new revision label 'Revision: v3.3.3' and removed the 'HHS Vulnerability Disclosure' footer link; these updates do not alter study information, eligibility criteria, or record history content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-12-23T21:56:43.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:39:32.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page no longer displays the temporary government funding notice banner. This header change does not affect study details or page functionality.
    Difference
    0.9%
    Check dated 2025-11-18T07:20:12.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    No substantive changes to the study record are evident; the version history shows the initial entry with the same details and the page layout remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T21:18:07.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    - Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    13%
    Check dated 2025-10-06T05:56:35.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.3%
    Check dated 2025-09-29T03:14:00.000Z thumbnail image

Stay in the know with updates to Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.